Close Menu

Cheap and Routine

Jay Flatley, the CEO of Illumina, told the UK's Times that by 2019, the genome sequencing of newborns will be routine and that in three to four years a genome sequence should be available for less than $1,000. "The limitations are sociological; when and where people think it can be applied, the concerns people have about misinformation and the background ethics questions," Flatley says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.